Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 103 results found. Search for [ Cadila Healthcare vaccine ]

Results 1 to 21 of 103
BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


Reuters
February 17, 2021
Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones


Reuters
February 12, 2021
In India, we are fortunate that supply of vaccines is not a rate-limiting step, but to meet the timelines set by the government, we will have to immunise somewhere between 4 and 5 times more people each day than we are doing today, says Gagandeep Kang of Christian Medical College in Vellore


Reuters
February 9, 2021
Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, starting with healthcare and other workers to reach the elderly and those with existing conditions by March


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
February 5, 2021
India Stock Market News Updates Today: Sensex scaled record high of 51,073.27 while the Nifty hit record high of 15,014.65 level in early trade. SBI, Kotak Bank, IndusInd Bank, HDFC, ONGC and Axis Bank were top gainers in the Sensex pack


Manoj Sharma | Mudit Kapoor
January 7, 2021
Initial 30 crore vaccinations (60 crore doses) planned by the Centre would have cost Rs 13,200 crore. However, need for 66 crore doses raises the cost by Rs 1320 crore


Ajita Shashidhar
January 7, 2021
Tarun Arora, CEO, Zydus Wellness said that the company, to begin with, is investing massively to improve the penetration of the Complan brand in mass markets


BusinessToday.In
January 4, 2021
Cadila Healthcare share touched an intraday high of Rs 492.95, rising 3.02% against previous close of Rs 478.50 on BSE


BusinessToday.In
January 4, 2021
Wearing a face mask is also crucial in India's fight against coronavirus because the government plans to inoculate 30 crore priority population over the next two months


BusinessToday.In
January 4, 2021
Stocks to watch today on January 4: Coal India, Hero MotoCorp, RCF, Cadila, BEML, TVS Motors among others are the top stocks to watch out for in Monday's  trading session


BusinessToday.In
December 19, 2020
The COVID-19 vaccine in India will be first offered to healthcare workers, frontline workers and persons above 50 years of age. Depending on the disease epidemiology and vaccine's availability, the remaining population will be vaccinated later on


Reuters
December 18, 2020
If India received a lower allocation of 95-125 million doses via COVAX, then the cost to the government of procuring additional shots would go up to $1.8 billion


PTI
December 17, 2020
Alka Sharma, an adviser with the Department of Biotechnology said more than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training programme


BusinessToday.In
December 13, 2020
VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system


BusinessToday.In
December 10, 2020
India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers


PTI
December 8, 2020
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation


BusinessToday.In
December 8, 2020
Coronavirus vaccine update: The ministry also said that India has eight coronavirus vaccine candidates in the making. Out of the eight, two have applied for emergency use authorisation


BusinessToday.In
December 5, 2020
DCGI VG Somani has said the CDSCO will facilitate analysis of interim clinical trial data at pre-defined stages. PM Modi says nearly eight vaccine candidates, out of which three are indigenously developed, are undergoing trials in India


BusinessToday.In
December 4, 2020
Centre is presently conducting extensive backend preparation for  COVID-19 immunisation drive. Government expects to receive and utilise 400-500 million doses and cover around 20-25 crore people by July 21


PAGES 1 OF 6  12345